Search results
Kansas sues Pfizer over COVID vaccine for what Kris Kobach calls 'misleading marketing'
The Topeka Capital-Journal via Yahoo News· 6 days ago"Texas' claims are made under their consumer protection act, so there are some differences. In...
Merck Prepares to Take on Pfizer After Pneumococcal Vaccine Approval
Barrons.com· 5 days agoPfizer currently dominates the market for pneumococcal vaccines, which protect against bacterial...
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia,...
NBC New York· 6 days agoThe Food and Drug Administration approved Merck's vaccine designed to protect adults from a bacteria...
Merck wins U.S. approval for pneumonia vaccine to rival Pfizer’s
Crain's New York Business· 6 days agoCapvaxive has the potential to become the preferred vaccine given studies have shown it protects...
MSD competes with Pfizer in pneumococcal vaccine market after FDA approval
Pharmaceutical Technology via Yahoo Finance· 5 days ago"MSD competes with Pfizer in pneumococcal vaccine market after FDA approval " was originally created...
New Pneumococcal Vaccine Approved
Medscape· 6 days agoThe new vaccine covers eight serotypes not protected by other vaccines already on the market.
COVID-19 is surging. Time to mask up or get a booster? What a Boise medical expert says
Idaho Statesman McClatchy via AOL· 3 days agoPeople 65 and older should get an additional dose 4 months after the previous one, according to the...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 3 days agoPfizer has also said it can jump in with a new pandemic influenza vaccine. Moderna stock has risen...
...NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation...
NewMediaWire via Yahoo Finance· 6 days ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen, ...